IntrinsicIntrinsic
← All summaries

Above Food Ingredients Inc.

ABVE
Financials & Chart →

Business Summary

Above Food Ingredients Inc. (New Above Food or the Company) operates as an Alberta-based innovative food company that leverages a vertically integrated supply chain to deliver differentiated ingredients and consumer products, with a vision to create a healthier world through chain of custody plant proteins, traceability, quantifiable sustainability, and nutrient density . The Company's business model is centered on two reportable segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods (CPG) . The Disruptive Agriculture and Rudimentary Ingredients segment focuses on discrete genetics, origination, purchasing, grading, primary processing, and sale of regeneratively grown grain, along with the origination, purchase, and sale of bespoke ingredient products processed through Company-owned facilities . The CPG segment is responsible for formulating, manufacturing, selling, distributing, and marketing proprietary consumer product formulations under owned brands, and also manufactures and distributes for private-labeled retail owned brands . The Company's revenue generation is primarily from commodity contracts related to forward sales of commodities like grain and pulses, rudimentary ingredients, subleasing of farmlands, and the sale of other products through consumer-packaged goods . A significant portion of the Disruptive Agriculture and Rudimentary Ingredients revenue is contracted over 3 to 12 months with customers .

For the fiscal year ended January 31, 2024 (FY24), the Company reported total revenue of $368,423,398 , a decrease of 7.1% from $396,464,504 in the fiscal year ended January 31, 2023 (FY23) . Cost of sales for FY24 was $374,322,146 , resulting in a gross loss of $5,898,748 . Operating loss for FY24 was $42,099,461 , and the net loss for the year was $53,312,282 . Diluted EPS for FY24 was $(0.69) . As of January 31, 2024, cash and cash equivalents stood at $952,280 , and the Company had an accumulated deficit of $103,880,258 . Total liabilities were $190,146,187 .

Comparing FY24 to FY23, revenue decreased by $28.0 million , primarily due to working capital constraints that limited growth in the disruptive agriculture and rudimentary ingredients segment, as well as price decreases in durum and other high-volume commodities . Disruptive Agriculture and Rudimentary Ingredients revenues decreased to $356.4 million in FY24 from $387.0 million in FY23 . CPG revenues, however, increased to $11.6 million in FY24 from $9.4 million in FY23 , largely attributed to acquisitions that closed in May and June 2022 being included for the full FY24 period . The gross loss increased by $4.6 million, or 361.0%, in FY24 compared to FY23, mainly due to inventory impairment and write-offs . Selling, general, and administrative (SG&A) expenses increased by $3.1 million, or 10.0%, in FY24, driven by higher professional fees related to the business combination and go-public process, and increased rent expenses, partially offset by decreased stock option expenses . Interest expense increased by $2.3 million to $7.7 million in FY24, due to new credit facilities and rising interest rates . The equity method investment loss increased by $3.0 million to $3.8 million in FY24, primarily due to a $3.3 million impairment of the investment in ANF .

During FY24, the Company completed the acquisition of Discovery Seed Labs Ltd. (DSL) on March 23, 2023, for $3,213,563, paid with $2 million cash and 502,088 class A common shares valued at $1,213,563 . This acquisition was considered a business combination and accounted for using the acquisition method . The Company also incurred approximately $3 million in inventory write-offs and write-downs, including a $2.7 million write-off of oat inventory due to discontinuance of the oat grower program and a $285,000 write-down of CPG inventory . Significant contract washout and cancellation costs, totaling approximately $650K, were incurred to exit unfavorable contracts .

Business Outlook

Above Food's growth strategy is centered on organic or internal growth, aiming for profitable and sustainable revenue growth through the sale of existing higher-margin products, expansion into new channels and customer acquisition, introduction of higher-margin products, building strategic partnerships, and continuous improvement in plants and organization to enhance efficiencies and simplify the business . The Company also plans for growth through acquisitions and securing long-term contracts . A significant percentage of the Disruptive Agriculture and Rudimentary Ingredients revenue is contracted over 3 to 12 months with customers, which management believes will contribute to stable revenues over time, although fluctuations have been experienced .

The Company intends to expand its existing credit facility to accommodate business growth and provide additional liquidity . This expansion is partly dependent on additional financing, including in connection with the Business Combination . If the credit facility expansion is unsuccessful, the Company may be forced to reduce operations and idle certain assets . Above is also exploring alternative asset-based lenders to increase available working capital and is currently in negotiations with lenders . Should these plans not be successful, Above would liquidate inventory as necessary, pay down the outstanding balance of the asset-backed lending line, and then utilize the line once working capital allows .

The Company expects to incur additional annual expenses related to being a publicly listed company, including directors' and officers' liability insurance, director fees, SEC reporting requirements, transfer agent fees, and increased auditing and legal fees . Management believes that the proceeds from the Business Combination, along with current available funds, will provide sufficient liquidity to fully fund future operations and any potential planned expansion of the business for at least the next twelve months . The Company may issue debt and/or equity securities on an opportunistic basis, dependent on market conditions and available pricing .

Risk Factors

The Company faces several material risks, including recurring losses from operations, a working capital deficiency of $85,414,272 as of January 31, 2024 , and violations of restrictive covenants related to approximately $66 million of its aggregate borrowings as of January 31, 2024 . There is no assurance that the Company will successfully obtain further equity and debt financing or maintain the support of current lenders, particularly concerning the indebtedness in default . The Company also expects to continue incurring recurring losses as it grows and has significant costs related to the business combination with Bite . Supply chain challenges, including higher raw material, freight, and logistics costs, and ingredient shortages, have persisted and are expected to continue in the 2025 fiscal year . Climate change poses long-term challenges, including physical risks from intense weather events, droughts, and changes in temperature and precipitation, which can impact operations, customers, and the supply chain . Evolving carbon regulations and global decarbonization ambitions could increase costs . The impact of climate changes on customer operations is uncertain and may be negative, and logistics bottlenecks due to adverse weather or poor highway conditions could delay product delivery . The Company's derivative contracts are not designated as accounting hedges, meaning changes in their fair value immediately affect earnings . A 5% increase in the U.S. Dollar exchange rate would have decreased net loss by $0.1 million for FY24 and $2.2 million for FY23 . A 10% increase in the price of various commodities traded would have increased net loss by $1.2 million for FY24 and $0.7 million for FY23 . A 1% increase in interest rates would increase interest expense by approximately $1.0 million for FY24 and $1.7 million for FY23 .

Management Priorities

Management's message to shareholders emphasizes a commitment to growth, both organically and through acquisitions, while navigating the complexities of becoming a public company. The Company's vision is to create a healthier world by leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, with a priority on chain of custody plant proteins, traceability, quantifiable sustainability, and nutrient density . Management explicitly states that the proceeds from the Business Combination, together with current available funds, are believed to provide sufficient liquidity to fully fund future operations and any potential planned expansion of the business for at least the next twelve months . Key strategic priorities include delivering profitable and sustainable revenue growth through existing higher-margin products, expanding into new channels and attracting new customers, introducing higher-margin products, building strategic partnerships, and investing in continuous improvement to enhance efficiencies and simplify the business . Additionally, growth through acquisitions and securing long-term contracts are highlighted as critical components of the growth strategy . Management also acknowledges the need to expand its existing credit facility to accommodate business growth and provide additional liquidity, noting that this is dependent on additional financing being raised .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 5, Operating and Financial Review and Prospects — Company Overview
  2. [2] Item 5, Operating and Financial Review and Prospects — Company Overview
  3. [3] Item 5, Operating and Financial Review and Prospects — Company Overview
  4. [4] Item 5, Operating and Financial Review and Prospects — Company Overview
  5. [5] Item 5, Operating and Financial Review and Prospects — Key Financial Definitions/Components of Results — Revenue
  6. [6] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  7. [7] Item 5, Operating and Financial Review and Prospects — Results of Operations — Revenue
  8. [8] Item 5, Operating and Financial Review and Prospects — Results of Operations — Revenue
  9. [9] Item 5, Operating and Financial Review and Prospects — Results of Operations — Cost of sales
  10. [10] Item 5, Operating and Financial Review and Prospects — Results of Operations — Gross profit (loss)
  11. [11] Item 5, Operating and Financial Review and Prospects — Results of Operations — Loss from operations
  12. [12] Item 5, Operating and Financial Review and Prospects — Results of Operations — Loss for the year
  13. [13] Item 5, Operating and Financial Review and Prospects — Results of Operations — Net loss per share of common share Basic and diluted
  14. [14] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  15. [15] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  16. [16] Item 3, Key Information — Capitalization and Indebtedness
  17. [17] Item 5, Operating and Financial Review and Prospects — Results of Operations — Revenue
  18. [18] Item 5, Operating and Financial Review and Prospects — Results of Operations — Revenue
  19. [19] Item 5, Operating and Financial Review and Prospects — Company Overview
  20. [20] Item 5, Operating and Financial Review and Prospects — Company Overview
  21. [21] Item 5, Operating and Financial Review and Prospects — Company Overview
  22. [22] Item 5, Operating and Financial Review and Prospects — Results of Operations — Gross profit (loss)
  23. [23] Item 5, Operating and Financial Review and Prospects — Results of Operations — Selling, general, and administrative (“SG&A”) expenses
  24. [24] Item 5, Operating and Financial Review and Prospects — Results of Operations — Interest expense
  25. [25] Item 5, Operating and Financial Review and Prospects — Results of Operations — Equity method investment loss
  26. [26] Item 5, Operating and Financial Review and Prospects — Acquisitions — Discovery Seed Labs
  27. [27] Item 5, Operating and Financial Review and Prospects — Acquisitions — Discovery Seed Labs
  28. [28] Item 5, Operating and Financial Review and Prospects — Business Trends Year Ended January 31, 2024, January 31, 2023, and January 31, 2022
  29. [29] Item 5, Operating and Financial Review and Prospects — Business Trends Year Ended January 31, 2024, January 31, 2023, and January 31, 2022
  30. [30] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  31. [31] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  32. [32] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  33. [33] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  34. [34] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  35. [35] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  36. [36] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  37. [37] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  38. [38] Item 5, Operating and Financial Review and Prospects — The Business Combination and Public Company Costs
  39. [39] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  40. [40] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  41. [41] Item 2, Summary of Significant Accounting Policies — Liquidity and Going Concern
  42. [42] Item 2, Summary of Significant Accounting Policies — Liquidity and Going Concern
  43. [43] Item 2, Summary of Significant Accounting Policies — Liquidity and Going Concern
  44. [44] Item 2, Summary of Significant Accounting Policies — Liquidity and Going Concern
  45. [45] Item 5, Operating and Financial Review and Prospects — Business Trends Year Ended January 31, 2024, January 31, 2023, and January 31, 2022 — Supply chains
  46. [46] Item 5, Operating and Financial Review and Prospects — Business Trends Year Ended January 31, 2024, January 31, 2023, and January 31, 2022 — Climate related trends
  47. [47] Item 5, Operating and Financial Review and Prospects — Business Trends Year Ended January 31, 2024, January 31, 2023, and January 31, 2022 — Climate related trends
  48. [48] Item 5, Operating and Financial Review and Prospects — Business Trends Year Ended January 31, 2024, January 31, 2023, and January 31, 2022 — Climate related trends
  49. [49] Item 5, Operating and Financial Review and Prospects — Business Trends Year Ended January 31, 2024, January 31, 2023, and January 31, 2022 — Climate related trends
  50. [50] Item 5, Operating and Financial Review and Prospects — Quantitative and Qualitative Disclosures About Market Risk — Foreign currency risk
  51. [51] Item 5, Operating and Financial Review and Prospects — Quantitative and Qualitative Disclosures About Market Risk — Commodity price risk
  52. [52] Item 5, Operating and Financial Review and Prospects — Quantitative and Qualitative Disclosures About Market Risk — Interest rate risk
  53. [53] Item 5, Operating and Financial Review and Prospects — Company Overview
  54. [54] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  55. [55] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  56. [56] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  57. [57] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources

Analysis on 5/22/2026